From GLP-1 to Triple Agonists: Transforming Cardiometabolic Care
Show: Science@UH
The pace of change in cardiometabolic medicine is accelerating. Ian Neeland, MD, breaks down the latest innovations in incretin therapies, from oral medications to cutting-edge combinations, and what they mean for weight loss, heart health, and long-term patient care.
- Learn more about Daniel Simon, MD
- Learn more about Ian Neeland, MD
- View our Science@UH video podcast on YouTube
- Learn more about the University Hospitals Research & Education Institute
More From Current Show
University Hospitals Reproductive Endocrinology and Infertility specialists, Rebecca Flyckt, MD, and Kathryn Coyne, MD, discuss a groundbreaking FDA-approved...
Listen Now Discover how a target identified in colon cancer research led to an unexpected opportunity to protect brain cells...
Listen Now Adonis Hijaz, MD and Goutham Rao, MD discuss the reasons why urinary incontinence is underreported and actionable strategies...
Listen Now Explore the rapidly evolving world of CAR‑T cell therapy and how scientists are reengineering the immune system to...
Listen Now 
Matthew Anderson, MD, PhD, and Tyler Miller, MD, PhD, discuss how immune biology is reshaping neuroscience - from...
Listen Now 
Jennifer Villwock, MD, explains the neurocircuitry of smell, her rapid essential-oil–based AROMA test, and how olfactory dysfunction can...
Listen Now 
Scrolling, Stress and the Teenage Brain: How EEG Biomarkers and Self-Management Can Change the Story
Molly McVoy, MD, dives into the mental health crisis affecting teens, why anxiety and depression have risen dramatically,...
Listen Now 
Theodoros Teknos, MD, and Gary Schwartz, MD, discuss how the recent $25.5 million NCI grant renewal solidifies Case...
Listen Now Related Episodes
No related episodes found.
